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SELF MANAGEMENT OF ASTHMA: DETERMINANTS OF 
WILLINGNESS TO PARTICIPATE IN A SELF 
MANAGEMENT PROGRAM
J den Otter. H ter Horst, B Thoonen, J Molema, C van 
Schayck & C van WeeL Nijmegen the Netherlands
Introduction: A lot of studies have been performed on self 
management of asthma programs (SMAP). Controlled 
studies did not detect a significant improvement of clinical 
outcome. A possible explanation is that the SMAP was 
also given to patients not interested in such a program. In 
this pilot-study we describe the willingness of asthma 
patients from one general practice to participate in a 
SMAP. Potential determinants studied included age, edu~ 
cation, gender, severeness and/or duration of disease and 
smoking habits.
Methods: All asthma patients known to the general practi­
tioner between 18-50 years were invited. AIL patients had 
a spirometry assessment, made an assessment of disease 
severity on a VAS-scale, control of inhaler technique, an 
interview using Wilsons criteria (Am J Med 1993; 94: 
564-75) and finally their willingness to participate in a 
SMAP was assessed. Results: 23 (15 female) out of 31 
participated. Mean age ± SD was 41 ± 9, mean duration 
18 ± 15. Overall inhaler technique was insufficient in 5 
patients. Objective and subjective severeness had 9 dis- 
concordant pairs. 14 Patients were willingly to participate 
in a SMAP. In this study no relation could be detected 
between education and willingness. Conclusion: Not all 
patients want to participate in a SMAP. Determinants of 
willingness to participate are: age, sex and objective and 
subjective severeness of asthma.
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THE EFFECTIVENESS OF BENZYL BENZOATE AND 
DIFFERENT CHEMICALS AS ACARICIDES
A. F. Kalpakijoglu*, A. G. Ferizli**, Z. Misirfiail*. Y. S. 
Demirel*} L. Gürbüz*, University of Ankara, *Faculty of 
Medicine, Department of Allergic Diseases, and 
**Facuity of Agriculture, Department of Plant Protec­
tion, Turkey
Several observations have incriminated that house dust 
mites play an important role in allergic diseases. Thus, 
allergen-avoidance measures have been demonstrated 
beneficial. Various chemical methods as well as physical 
measures have been tried to eliminate mite allergens from 
house dust. In this study, the acaricidal activities of phenyl 
salicylate, tea (high tannic asid content) and essential oils 
(eucalyptus and laurel) compared to benzyl benzoate were 
investigated. The contact, persistence and the residual 
effect of various concentrations of these chemicals and 
benzyl benzoate were assessed using specially designed 
wells. Our data suggested that, benzyl benzoate may be 
effective when applied more frequently (i.e.three-four 
times a year) than the manufacturer's instructions, and for 
longer periods (i.e.24 hours) even with lower concentra­
tions. Essential oils were shown to have little effect on live 
mites, but almost no acaricidal activity had been observed
with tea. Amongst the chemicals used, phenyl salicylate 
could be assumed promising as an alternative acaricide. 
Key words: Acaricide, benzyl benzoate, phenyl salicylate, 
tea
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IMMUNOMODULATORY EFFECT OF BRONCHOVAXOM 
IN CHILDREN WITH ATOPIC BRONCHIAL ASTHMA 
AND DYSFUNCTION OF T LYMPHOCYTES
A. Stasiak-Barmuta. T. Piotrowska, J. Hofman, Bia- 
lystok, Poland
In atopic children, the respiratory tract infections can 
stimulate the bronchial hyperreactivity. Many investiga­
tions demonstrate the dependences between infections and 
T cell dysfunction.. The aim of this study was to assess 
immunomodulatory effect of Broncho-Vaxom in children 
with atopic bronchial asthma and concomitant recurrent 
respiratory tract infections.
30 children (4-16 years old) were included in this study. 
The immunological parameters as a number of T cells by 
E rossetting test according to WHO criteria, serum level of 
IgA,M,G (turbidimetric method) and IgE (fluorimetric 
method) were examined. Children were treated using a 
"prophylactic*' schedule i.e. one capsule of B-V of 3.5 mg 
daily for 10 days during three consecutive months. After 
finishing of B-V therapy the significant increasing espe- 
cialy of total E rossettes and percentage of T cells in leu- 
cogram were observed. This changes has been correlate 
with the clinical improvement manifested by the decreas­
ing of a number of infections episodes. In our opinion in 
atopic bronchial asthma with concomitant recurrent respi­
ratory tract infections the immunomodulation therapy 
should be performed.
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BR0NCH0-VAX0M IN RECURRENT RESPIRATORY 
INFECTIONS IN ADULT PATIENTS WITH ATOPIC 
ASTHMA-MULTICENTRE STUDY
J. Malolepsky, B. Panaszek, R. Dobek. W. Medrala, G. 
Czerniawska-Mysik, T. Adamek-Guzik, K. Prochowska- 
Mitka, E. Rogaia, J. Jarzab, B. Rogaia, M. Nowak- 
owski, Poland
A multicentre clinical study was performed in 81 adults 
with atopic asthma to evaluate the effects of treatment 
Broncho-Vaxom (BV). Fifty five patients received BV for 
a period of 5 months while the other 26 subjects only 
conventional therapy. Symptoms score, lung function tests 
and some immunological parameters including ECP, lym­
phocytes CD4 and CD8, sCD23, IgE, IgG, IgGl, IgG2, 
and IgG3 were observed during the study. On the BV 
therapy there was a significant reduction of cumulative 
index of symptoms at all visits in comparison to entry 
values (pcO.OOOl) and also to respective control group 
values (p<0.05) Evaluation of lung function tests revealed 
significant PEF improvement at all visits in BV group 
when compared to values at entry and to values in the 
control group (p<0.05). We have also noticed significant
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